Related references
Note: Only part of the references are listed.Integrating the monoamine, neurotrophin and cytokine hypotheses of depression - A central role for the serotonin transporter?
Jana Haase et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication
Mathias Rask-Andersen et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
Kamlesh Sodani et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model
Horrick Sharma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Radoslaw Polanski et al.
CLINICAL CANCER RESEARCH (2014)
Using Positron Emission Tomography to Study Transporter-Mediated Drug-Drug Interactions in Tissues
B. Wulkersdorfer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
T. Forst et al.
DIABETES OBESITY & METABOLISM (2014)
Canagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Greg L. Plosker
DRUGS (2014)
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection
Qiongman Kong et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
Ele Ferrannini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
In Vivo Detection of Monoaminergic Degeneration in Early Parkinson Disease by F-18-9-Fluoropropyl-(+)-Dihydrotetrabenzazine PET
Shao-Cheng Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Genetic Implication of a Novel Thiamine Transporter in Human Hypertension
Kuixing Zhang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors
Raymond V. Oliva et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Loss-of-function mutations in SLC30A8 protect against type 2 diabetes
Jason Flannick et al.
NATURE GENETICS (2014)
Physiology and pathophysiology of SLC12A1/2 transporters
Nicolas Markadieu et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Glycine transport inhibitors for the treatment of pain
Robert J. Vandenberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters
Zachary Lee Johnson et al.
ELIFE (2014)
Bitopertin The Good News and Bad News
Donald C. Goff
JAMA PSYCHIATRY (2014)
The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke's Encephalopathy
Qiang Zhang et al.
DRUG METABOLISM AND DISPOSITION (2014)
New Fluorescent Substrate Enables Quantitative and High-Throughput Examination of Vesicular Monoamine Transporter 2 (VMAT2)
Gang Hu et al.
ACS CHEMICAL BIOLOGY (2013)
New Therapies for Gout
Daria B. Crittenden et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
The synthesis and biodistribution of [11C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo
W. Ewan Hume et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
Inside Out: Targeting NHE1 as an Intracellular and Extracellular Regulator of Cancer Progression
Joseph J. Provost et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Cystic Fibrosis Therapeutics The Road Ahead
Lucas R. Hoffman et al.
CHEST (2013)
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein et al.
CLINICAL CANCER RESEARCH (2013)
Study Design and Rationale of a Dose-Ranging Trial of LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
Pablo Lapuerta et al.
CLINICAL CARDIOLOGY (2013)
SLC Classification: An Update
A. Schlessinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Molecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters
Avner Schlessinger et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence
Ann M. Manzardo et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response
Inna Y. Gong et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
A Genome-Wide Association Study for Serum Bilirubin Levels and Gene-Environment Interaction in a Chinese Population
Xiayun Dai et al.
GENETIC EPIDEMIOLOGY (2013)
Hunting human disease genes: lessons from the past, challenges for the future
Liam R. Brunham et al.
HUMAN GENETICS (2013)
Riluzole increases glutamate uptake by cultured C6 astroglial cells
Oscar P. Dall'Igna et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2013)
Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2
Tsuyoshi Nogami et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance
Motoyuki Tamaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer
Ryusuke Takebayashi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Hereditary conjugated hyperbilirubinaemia: 37 years later
Daniel Dhumeaux et al.
JOURNAL OF HEPATOLOGY (2013)
Synthesis and Biological Evaluation of New Creatine Fatty Esters Revealed Dodecyl Creatine Ester as a Promising Drug Candidate for the Treatment of the Creatine Transporter Deficiency
Alexandra Trotier-Faurion et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling
Matthias B. Wittwer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes
Yulin Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain
Bjarke Abrahamsen et al.
JOURNAL OF NEUROSCIENCE (2013)
The SLC1 high-affinity glutamate and neutral amino acid transporter family
Yoshikatsu Kanai et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Solute carriers as drug targets: Current use, clinical trials and prospective
Mathias Rask-Andersen et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
The SLCO (former SLC21) superfamily of transporters
Bruno Hagenbuch et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Solute carriers (SLCs) in cancer
Sara El-Gebali et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
The ABCs of membrane transporters in health and disease (SLC series): Introduction
Matthias A. Hediger et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
The solute carrier family 10 (SLC10): Beyond bile acid transport
Tatiana Claro da Silva et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
The SLC3 and SLC7 families of amino acid transporters
Dimitrios Fotiadis et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Glucose transport families SLC5 and SLC50
Ernest M. Wright
MOLECULAR ASPECTS OF MEDICINE (2013)
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
William T. Cefalu et al.
LANCET (2013)
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Aravind Penmatsa et al.
NATURE (2013)
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Anna Koettgen et al.
NATURE GENETICS (2013)
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain
Robert J. Harvey et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Chemical predictive modelling to improve compound quality
John G. Cumming et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Vera Miranda-Goncalves et al.
NEURO-ONCOLOGY (2013)
CHRONIC BRAIN ISCHEMIA INDUCES THE EXPRESSION OF GLIAL GLUTAMATE TRANSPORTER EAAT2 IN SUBCORTICAL WHITE MATTER
Y. Yatomi et al.
NEUROSCIENCE (2013)
Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1
Ethan G. Geier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Na+-H+ Exchanger, pH Regulation and Cancer
Stephan J. Reshkin et al.
Recent Patents on Anti-Cancer Drug Discovery (2013)
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study
Akihiro Takano et al.
PSYCHOPHARMACOLOGY (2013)
Early Identification of Clinically Relevant Drug Interactions With the Human Bile Salt Export Pump (BSEP/ABCB11)
Jenny M. Pedersen et al.
TOXICOLOGICAL SCIENCES (2013)
Nutrient transporters: the Achilles' heel of anabolism
Alison N. McCracken et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Genetics of Hyperuricemia and Gout: Implications for the Present and Future
Ronald L. George et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Substrate-Dependent Inhibition of Organic Anion Transporting Polypeptide 1B1: Comparative Analysis with Prototypical Probe Substrates Estradiol-17β-Glucuronide, Estrone-3-Sulfate, and Sulfobromophthaleins
Saki Izumi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Monoamine Transporter Occupancy of a Novel Triple Reuptake Inhibitor in Baboons and Humans Using Positron Emission Tomography
Robert A. Comley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
In Vitro 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake: Practical Considerations
Koen Mertens et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Structural Exploration of (3S,6S)-6-Benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine Analogues: Identification of Potent Triple Monoamine Reuptake Inhibitors as Potential Antidepressants
Soumava Santra et al.
CHEMMEDCHEM (2012)
LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
B. Zambrowicz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
New Clinical Perspectives of Hypolipidemic Drug Therapy in Severe Hypercholesterolemia
C. Stefanutti et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Fan-Lin Kong et al.
CURRENT MEDICINAL CHEMISTRY (2012)
NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
Ser Yue Loo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose-Absorption and Glucose-Dependent Incretin Secretion
Valentin Gorboulev et al.
DIABETES (2012)
Glycine Transporter Type 2 (GlyT2) Inhibitor Ameliorates Bladder Overactivity and Nociceptive Behavior in Rats
Satoru Yoshikawa et al.
EUROPEAN UROLOGY (2012)
Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases
Chien-Liang Glenn Lin et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy
Young Mok Lee et al.
HEPATOLOGY (2012)
High Selectivity of the γ-Aminobutyric Acid Transporter 2 (GAT-2, SLC6A13) Revealed by Structure-based Approach
Avner Schlessinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Yuko Kurosawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver
Evita van de Steeg et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Structure-Activity Relationship Study of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitor 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H- chromene-3-carbonitrile (UCPH-101) and Absolute Configurational Assignment Using Infrared and Vibrational Circular Dichroism Spectroscopy in Combination with ab Initio Hartree-Fock Calculations
Tri H. V. Huynh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of Tofogliflozin, a Novel C-Arylglucoside with an O-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
Yoshihito Ohtake et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å
Zachary Lee Johnson et al.
NATURE (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
Marica Carbone et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
Feng Zhu et al.
NUCLEIC ACIDS RESEARCH (2012)
Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice
Thomas Lundasen et al.
PLOS ONE (2012)
Pharmacological Estrogen Administration Causes a FSH-Independent Osteo-Anabolic Effect Requiring ER Alpha in Osteoblasts
Sebastian Seitz et al.
PLOS ONE (2012)
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
Eimear E. Kenny et al.
PLOS GENETICS (2012)
KGA-2727, a Novel Selective Inhibitor of a High-Affinity Sodium Glucose Cotransporter (SGLT1), Exhibits Antidiabetic Efficacy in Rodent Models
Toshihide Shibazaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
A Pairwise Chemical Genetic Screen Identifies New Inhibitors of Glucose Transport
Olesya A. Ulanovskaya et al.
CHEMISTRY & BIOLOGY (2011)
Pharmacophore Modelling: A Forty Year Old Approach and its Modern Synergies
F. Caporuscio et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
Joseph Jankovic et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele
Adrienne Tin et al.
HUMAN MOLECULAR GENETICS (2011)
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene
Thorunn Rafnar et al.
HUMAN MOLECULAR GENETICS (2011)
Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
Yasuto Kido et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and In Vitro Evaluation of Gabapentin Prodrugs That Target the Human Apical Sodium-Dependent Bile Acid Transporter (hASBT)
Rana Rais et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Novel Breast Cancer Susceptibility Locus at 9q31.2: Results of a Genome-Wide Association Study
Olivia Fletcher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret et al.
NATURE (2011)
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
Louise V. Wain et al.
NATURE GENETICS (2011)
Exome sequencing as a tool for Mendelian disease gene discovery
Michael J. Bamshad et al.
NATURE REVIEWS GENETICS (2011)
Mayo Genome Consortia: A Genotype-Phenotype Resource for Genome-Wide Association Studies With an Application to the Analysis of Circulating Bilirubin Levels
Suzette J. Bielinski et al.
MAYO CLINIC PROCEEDINGS (2011)
Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration
Richard W. Daniels et al.
NEUROBIOLOGY OF DISEASE (2011)
Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS
Amanda J. Weeks et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Anders S. Kristensen et al.
PHARMACOLOGICAL REVIEWS (2011)
Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET
Avner Schlessinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
Renaud Le Floch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Urate Transporters: An Evolving Field
Naohiko Anzai et al.
SEMINARS IN NEPHROLOGY (2011)
Biotin-Responsive Basal Ganglia Disease in Ethnic Europeans With Novel SLC19A3 Mutations
Rabab Debs et al.
ARCHIVES OF NEUROLOGY (2010)
Structural Requirements of the ASBT by 3D-QSAR Analysis Using Aminopyridine Conjugates of Chenodeoxycholic Acid
Xiaowan Zheng et al.
BIOCONJUGATE CHEMISTRY (2010)
Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
B. C. Cheah et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Apparent activity in high-throughput screening: origins of compound-dependent assay interference
Natasha Thorne et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
PET Radioligands for the Vesicular Acetylcholine Transporter (VAChT)
Nicolas Giboureau et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Synthesis and biological evaluation of [18F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter
Maite Jauregui-Osoro et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation
Kelly M. Kennedy et al.
FUTURE ONCOLOGY (2010)
Impaired Intestinal Vitamin B1 (Thiamin) Uptake in Thiamin Transporter-2-Deficient Mice
Jack C. Reidling et al.
GASTROENTEROLOGY (2010)
Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma
Celine Pinheiro et al.
HISTOPATHOLOGY (2010)
Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate
Promsuk Jutabha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Kinetics and Specificity of Feline Leukemia Virus Subgroup C Receptor (FLVCR) Export Function and Its Dependence on Hemopexin
Zhantao Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of Selective Norbornane-Type Aspartate Analogue Inhibitors of the Glutamate Transporter 1 (GLT-1) from the Chemical Universe Generated Database (GDB)
Erika Luethi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Quantitative Analyses of Aggregation, Autofluorescence, and Reactivity Artifacts in a Screen for Inhibitors of a Thiol Protease
Ajit Jadhav et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease
Randall L. Woltjer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Treatment of intractable epilepsy in a female with SLC6A8 deficiency
Saadet Mercimek-Mahmutoglu et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Exome sequencing identifies the cause of a mendelian disorder
Sarah B. Ng et al.
NATURE GENETICS (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Update on gout: new therapeutic strategies and options
Robert Terkeltaub
NATURE REVIEWS RHEUMATOLOGY (2010)
Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity
Craig K. Colton et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression
Vito Iacobazzi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The x c - cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
Jun Guan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Insulin Storage and Glucose Homeostasis in Mice Null for the Granule Zinc Transporter ZnT8 and Studies of the Type 2 Diabetes-Associated Variants
Tamara J. Nicolson et al.
DIABETES (2009)
Bile Acids and Metabolic Regulation Mechanisms and clinical responses to bile acid sequestration
Bart Staels et al.
DIABETES CARE (2009)
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
Yoshikazu Fujimori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Genome-wide association meta-analysis for total serum bilirubin levels
Andrew D. Johnson et al.
HUMAN MOLECULAR GENETICS (2009)
Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia
Serena Sanna et al.
HUMAN MOLECULAR GENETICS (2009)
Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice
Wai Han Yiu et al.
JOURNAL OF HEPATOLOGY (2009)
Genome-Wide Association Study of Tanning Phenotype in a Population of European Ancestry
Hongmei Nan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Computational Models for Drug Inhibition of the Human Apical Sodium-Dependent Bile Acid Transporter
Xiaowan Zheng et al.
MOLECULAR PHARMACEUTICS (2009)
Mutations in a Thiamine-Transporter Gene and Wernicke's-like Encephalopathy
Satoshi Kono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
Vadivel Ganapathy et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921
Shingo Sakamoto et al.
DRUG METABOLISM AND DISPOSITION (2008)
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
Elena Fumagalli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Impact on bone of an estrogen receptor-α gene loss of function mutation
Eric P. Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)
Jenny M. Pedersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands
Iain J. A. MacDougall et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice
Katsuya Morita et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models
Yoshikazu Fujimori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Apical transporters for neutral amino acids: Physiology and pathophysiology
Stefan Broeer
PHYSIOLOGY (2008)
A genomewide association study of skin pigmentation in a South Asian population
Renee P. Stokowski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The GLUT9 gene is associated with serum uric acid levels in Sardinia and chianti cohorts
Siguang Li et al.
PLOS GENETICS (2007)
Tetrapeptide inhibitors of the glutamate vesicular transporter (VGLUT)
Sarjubhai A. Patel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake
Zheng Zhou et al.
SCIENCE (2007)
Cheerful news for antidepressant research
Simon Hadlington
CHEMISTRY WORLD (2007)
Antidepressant binding site in a bacterial homologue of neurotransmitter transporters
Satinder K. Singh et al.
NATURE (2007)
Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action
Shingo Sakamoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Laura J. Scott et al.
SCIENCE (2007)
A high-throughput screen for aggregation-based inhibition in a large compound library
Brian Y. Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
A genome-wide association study identifies novel risk loci for type 2 diabetes
Robert Sladek et al.
NATURE (2007)
Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice
W. H. Yiu et al.
GENE THERAPY (2007)
Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics
Rachel E. Airley et al.
CHEMOTHERAPY (2007)
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Kenji Katsuno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia
Marjorie J. Lindhurst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors
Hiroshi Nawashiro et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Apical sodium dependent bile acid transporter (ASBT, SLC10A2): A potential prodrug target
Anand Balakrishnan et al.
MOLECULAR PHARMACEUTICS (2006)
Monocarboxylate transporter MCT1 is a target for immunosuppression
CM Murray et al.
NATURE CHEMICAL BIOLOGY (2005)
The substituted aspartate analogue L-β-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3
CS Esslinger et al.
NEUROPHARMACOLOGY (2005)
Glutamate Transporters as Drug Targets
Eiichi Hinoi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Inhibitors of the glutamate vesicular transporter (VGLUT)
CM Thompson et al.
CURRENT MEDICINAL CHEMISTRY (2005)
The SLC22 drug transporter family
H Koepsell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese
N Iwai et al.
KIDNEY INTERNATIONAL (2004)
Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice
H Guo et al.
HUMAN MOLECULAR GENETICS (2003)
Islet β-cell secretion determines glucagon release from neighbouring α-cells
H Ishihara et al.
NATURE CELL BIOLOGY (2003)
Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice
A Schmitt et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)
ZZ Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Amish lethal microcephaly: A new metabolic disorder with severe congenital microcephaly and 2-ketoglutaric aciduria
RI Kelley et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Mutant deoxynucleotide carrier is associated with congenital microcephaly
MJ Rosenberg et al.
NATURE GENETICS (2002)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport
CN Carrigan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Further insight into mechanism of action of clodronate:: Inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite
PP Lehenkari et al.
MOLECULAR PHARMACOLOGY (2002)
Increased [H-3]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia
I Sundman-Eriksson et al.
NEUROPSYCHOBIOLOGY (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
Zinc as a paracrine effector in pancreatic islet cell death
BJ Kim et al.
DIABETES (2000)